Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD)

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

18 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-04-30

Study Completion Date

2011-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An extension study for subjects with prior participation in previous resonator studies using low level magnetic fields to treat some of the symptoms of idiopathic Parkinson's Disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of the Application of Magnetic Fields for the Treatment of Parkinson's Disease

NCT00863226

Parkinson's Disease Quality of Life

UNKNOWN PHASE3

Study on the Effect of External Magnetic Stimulation on Patients With Parkinson's Disease

NCT00841464

Parkinson's Disease

COMPLETED

Transcranial Magnetic Stimulation in Parkinson's Disease

NCT00023062

Parkinson Disease Healthy

COMPLETED

Using Low Intensity Focused Ultrasound to Modulate Deep Brain Areas for Tremor Control in Parkinson's Disease Patients.

NCT06259708

Parkinson Disease

ACTIVE_NOT_RECRUITING NA

The Effect of Repetitive Transcranial Magnetic Stimulation on the Cognition in People With Parkinson's Disease

NCT04698928

Parkinson Disease With Dementia

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson's Disease

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active Resonator magnetic field therapy

Administration of active magnetic fields with the Resonator Device

Resonator Device

Intervention Type DEVICE

active pico-tesla magnetic fields treatment for Parkinson's disease individuals

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Resonator Device

active pico-tesla magnetic fields treatment for Parkinson's disease individuals

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Prior participation in pico-tesla pilot studies: NCT00779155 \& NCT00863226
* Willing and able to abstain from partaking in non-essential new treatments for Parkinson's disease symptoms during the course of participation of the study.
* Will and able to abstain from all non-essential new medications that could affect PD and/or any of its associated symptoms for the duration of the study.
* Willing to notify the investigator right away of any changes in medication use or therapies that is prescribed and deemed necessary by the subjects physicians.
* Adequate contraceptive measures for female subjects
* Capable of giving full written informed consent

Exclusion Criteria

* Not a participant in IRC#'s 07102 or 07021
* No active brain tumors, strokes, hydrocephalus
* Chronic pain not associated with PD
* Any other condition which might prevent subject from comfortably sitting for 1.5 hours
* Consumption of medications that can produce Parkinsonism type symptoms
* Major psychiatric disturbance
* Epilepsy
* HIv and other autoimmune disorders
* Cancer within last 2 years
* History of ECt
* Diabetic neuropathy
* Uncontrolled HTN
* Advanced Pulmonary disease
* Known heart conditions such as repetitive history of cardiac arrythmias
* Previous surgeries for PD
* Prosthetics comprised of ferrous materials
* Stents, only where there is also cardiac arrythmias, CHF, advanced valvular stenosis, unstable vital signs, extensive ischemic damage to heart muscle as a result of one or more heart attacks.
* Pacemakers
* Uncontrolled, unstable, or untreated medical illnesses which might potentially significantly affect the patient's health in the opinion of the investigator
* Consumption of more than 21 alcoholic drinks per week
* Pregnant, breast feeding or planning pregnancy
* Developmental disability or cognitive impairment
* Inability to maintain regular medication regime
* Inability to abstain from partaking in new non-essential PD tx., or medications
* Not willing to report physician mandated changes in medication and/or treatment

Minimum Eligible Age

30 Years

Maximum Eligible Age

82 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No